Zai Lab (MEX:ZLAB N) Total Long-Term Assets: MXN2,723 Mil (As of Mar. 2026)


MEX:ZLAB N Zai Lab Ltd MEX:ZLAB N
64 GF Score
Price MXN810.00
GF Value MXN1,280.93
! 8 Warning Signs
View Full Analysis

What is Zai Lab Total Long-Term Assets?

Zai Lab MEX:ZLAB N 64 Total Long-Term Assets is MXN2,723 Mil as of Mar. 2026. GuruFocus rates MEX:ZLAB N with a GF Score™ of 64/100 and a GF Value™ of MXN1,280.93. The stock has 8 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Zai Lab's Total Long-Term Assets for the quarter that ended in Mar. 2026 was MXN2,723 Mil.

Zai Lab Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Zai Lab's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zai Lab Total Long-Term Assets Chart

Zai Lab Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,237.56 1,867.79 1,641.22 2,821.21 2,756.64

Zai Lab Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,689.48 2,448.53 2,311.22 2,756.64 2,723.08
MEX:ZLAB N
64GF Score
Zai Lab Ltd MEX:ZLAB N
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zai Lab Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of MXN2,723 Mil mean?
Zai Lab (MEX:ZLAB N) has a Total Long-Term Assets of MXN2,723 Mil as of Mar. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Zai Lab and its competitors.
Is Zai Lab's Total Long-Term Assets too high?
Zai Lab's current Total Long-Term Assets is MXN2,723 Mil. Overall, Zai Lab has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Zai Lab's Total Long-Term Assets compare to STOK and ADMA?
Zai Lab's Total Long-Term Assets of MXN2,723 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Biotechnology company?
A good Total Long-Term Assets depends on the Biotechnology industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Zai Lab and its competitors. Zai Lab's current Total Long-Term Assets is MXN2,723 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zai Lab stock overvalued right now?
Zai Lab (MEX:ZLAB N) has a current Total Long-Term Assets of MXN2,723 Mil. The stock's GF Value™ is MXN1,280.93, compared to a current price of MXN810.00 — trading 36.8% below its estimated fair value. The current Total Long-Term Assets is MXN2,723 Mil. Zai Lab's overall GF Score™ is 64/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Zai Lab (MEX:ZLAB N), the current Total Long-Term Assets is MXN2,723 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zai Lab (MEX:ZLAB N) Overvalued in 2026?

Based on GuruFocus' analysis, Zai Lab stock appears to be undervalued. The current stock price of MXN810.00 is trading 36.8% below its estimated GF Value™ of MXN1,280.93.

Key valuation signals for MEX:ZLAB N:

  • Total Long-Term Assets: MXN2,723 Mil
  • GF Value™: MXN1,280.93 vs. price of MXN810.00 (36.8% below fair value)
  • GF Score™: 64/100 with 8 warning signs

No single metric tells the full story. See the MEX:ZLAB N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zai Lab Business Description

Address 899 Halei Road, Building B, Pudong, Shanghai, CHN, 201203
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
64GF Score

Get the complete analysis for MEX:ZLAB N

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN810.00
Price
MXN1,280.93
GF Value